Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
27
RMSYF Quote, Financials, Valuation and Earnings
Last price:
$20.00
Seasonality move
:
3.36%
Day range:
$20.00 - $20.00
52-week range:
$19.00 - $25.51
Dividend yield:
0%
P/E ratio:
4,444.44x
P/S ratio:
0.40x
P/B ratio:
2.08x
Volume:
--
Avg. volume:
59
1-year change:
-16.67%
Market cap:
$4.6B
Revenue:
$11.5B
EPS (TTM):
$0.01
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
RMSYF
Ramsay Health Care Ltd.
|
-- | -- | -- | -- | -- |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | -- | -- | -- | $12.00 |
|
IMMP
Immutep Ltd.
|
-- | -- | -- | -- | $9.50 |
|
KZIA
Kazia Therapeutics Ltd.
|
-- | -- | -- | -- | $16.49 |
|
MESO
Mesoblast Ltd.
|
$20.3M | -- | -100% | -- | $35.00 |
|
PPCB
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
RMSYF
Ramsay Health Care Ltd.
|
$20.00 | -- | $4.6B | 4,444.44x | $0.25 | 0% | 0.40x |
|
ATHE
Alterity Therapeutics Ltd.
|
$3.42 | $12.00 | $62M | -- | $0.00 | 0% | 3.58x |
|
IMMP
Immutep Ltd.
|
$1.80 | $9.50 | $262M | -- | $0.00 | 0% | -- |
|
KZIA
Kazia Therapeutics Ltd.
|
$15.05 | $16.49 | $25.1M | -- | $0.00 | 0% | 680.02x |
|
MESO
Mesoblast Ltd.
|
$17.87 | $35.00 | $2.3B | -- | $0.00 | 0% | 125.41x |
|
PPCB
|
$11.98 | -- | $158.1K | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
RMSYF
Ramsay Health Care Ltd.
|
70.04% | 1.452 | -- | 0.73x |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | -1.575 | -- | -- |
|
IMMP
Immutep Ltd.
|
-- | 0.640 | -- | -- |
|
KZIA
Kazia Therapeutics Ltd.
|
-6.76% | 5.445 | 5.57% | 0.07x |
|
MESO
Mesoblast Ltd.
|
-- | 0.345 | -- | -- |
|
PPCB
|
-- | 4.794 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
RMSYF
Ramsay Health Care Ltd.
|
-- | -- | 0.18% | 0.49% | -- | -- |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | -- | -- | -- | -- | -- |
|
IMMP
Immutep Ltd.
|
-- | -- | -- | -- | -- | -- |
|
KZIA
Kazia Therapeutics Ltd.
|
-- | -- | -784.09% | -1083.16% | -- | -- |
|
MESO
Mesoblast Ltd.
|
-- | -- | -- | -- | -- | -- |
|
PPCB
|
-- | -$290.8K | -- | -- | -- | -$235.5K |
Ramsay Health Care Ltd. vs. Competitors
-
Which has Higher Returns RMSYF or ATHE?
Alterity Therapeutics Ltd. has a net margin of -- compared to Ramsay Health Care Ltd.'s net margin of --. Ramsay Health Care Ltd.'s return on equity of 0.49% beat Alterity Therapeutics Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RMSYFRamsay Health Care Ltd.-- -- $10.4B ATHEAlterity Therapeutics Ltd.-- -- -- -
What do Analysts Say About RMSYF or ATHE?
Ramsay Health Care Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Alterity Therapeutics Ltd. has an analysts' consensus of $12.00 which suggests that it could grow by 250.88%. Given that Alterity Therapeutics Ltd. has higher upside potential than Ramsay Health Care Ltd., analysts believe Alterity Therapeutics Ltd. is more attractive than Ramsay Health Care Ltd..
Company Buy Ratings Hold Ratings Sell Ratings RMSYFRamsay Health Care Ltd.0 0 0 ATHEAlterity Therapeutics Ltd.0 0 0 -
Is RMSYF or ATHE More Risky?
Ramsay Health Care Ltd. has a beta of 0.096, which suggesting that the stock is 90.419% less volatile than S&P 500. In comparison Alterity Therapeutics Ltd. has a beta of 0.023, suggesting its less volatile than the S&P 500 by 97.656%.
-
Which is a Better Dividend Stock RMSYF or ATHE?
Ramsay Health Care Ltd. has a quarterly dividend of $0.25 per share corresponding to a yield of 0%. Alterity Therapeutics Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ramsay Health Care Ltd. pays 2698.46% of its earnings as a dividend. Alterity Therapeutics Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RMSYF or ATHE?
Ramsay Health Care Ltd. quarterly revenues are --, which are smaller than Alterity Therapeutics Ltd. quarterly revenues of --. Ramsay Health Care Ltd.'s net income of -- is lower than Alterity Therapeutics Ltd.'s net income of --. Notably, Ramsay Health Care Ltd.'s price-to-earnings ratio is 4,444.44x while Alterity Therapeutics Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ramsay Health Care Ltd. is 0.40x versus 3.58x for Alterity Therapeutics Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RMSYFRamsay Health Care Ltd.0.40x 4,444.44x -- -- ATHEAlterity Therapeutics Ltd.3.58x -- -- --
-
Which has Higher Returns RMSYF or IMMP?
Immutep Ltd. has a net margin of -- compared to Ramsay Health Care Ltd.'s net margin of --. Ramsay Health Care Ltd.'s return on equity of 0.49% beat Immutep Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RMSYFRamsay Health Care Ltd.-- -- $10.4B IMMPImmutep Ltd.-- -- -- -
What do Analysts Say About RMSYF or IMMP?
Ramsay Health Care Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Immutep Ltd. has an analysts' consensus of $9.50 which suggests that it could grow by 427.78%. Given that Immutep Ltd. has higher upside potential than Ramsay Health Care Ltd., analysts believe Immutep Ltd. is more attractive than Ramsay Health Care Ltd..
Company Buy Ratings Hold Ratings Sell Ratings RMSYFRamsay Health Care Ltd.0 0 0 IMMPImmutep Ltd.1 0 0 -
Is RMSYF or IMMP More Risky?
Ramsay Health Care Ltd. has a beta of 0.096, which suggesting that the stock is 90.419% less volatile than S&P 500. In comparison Immutep Ltd. has a beta of 1.925, suggesting its more volatile than the S&P 500 by 92.469%.
-
Which is a Better Dividend Stock RMSYF or IMMP?
Ramsay Health Care Ltd. has a quarterly dividend of $0.25 per share corresponding to a yield of 0%. Immutep Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ramsay Health Care Ltd. pays 2698.46% of its earnings as a dividend. Immutep Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RMSYF or IMMP?
Ramsay Health Care Ltd. quarterly revenues are --, which are smaller than Immutep Ltd. quarterly revenues of --. Ramsay Health Care Ltd.'s net income of -- is lower than Immutep Ltd.'s net income of --. Notably, Ramsay Health Care Ltd.'s price-to-earnings ratio is 4,444.44x while Immutep Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ramsay Health Care Ltd. is 0.40x versus -- for Immutep Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RMSYFRamsay Health Care Ltd.0.40x 4,444.44x -- -- IMMPImmutep Ltd.-- -- -- --
-
Which has Higher Returns RMSYF or KZIA?
Kazia Therapeutics Ltd. has a net margin of -- compared to Ramsay Health Care Ltd.'s net margin of --. Ramsay Health Care Ltd.'s return on equity of 0.49% beat Kazia Therapeutics Ltd.'s return on equity of -1083.16%.
Company Gross Margin Earnings Per Share Invested Capital RMSYFRamsay Health Care Ltd.-- -- $10.4B KZIAKazia Therapeutics Ltd.-- -- -$6.3M -
What do Analysts Say About RMSYF or KZIA?
Ramsay Health Care Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Kazia Therapeutics Ltd. has an analysts' consensus of $16.49 which suggests that it could grow by 9.6%. Given that Kazia Therapeutics Ltd. has higher upside potential than Ramsay Health Care Ltd., analysts believe Kazia Therapeutics Ltd. is more attractive than Ramsay Health Care Ltd..
Company Buy Ratings Hold Ratings Sell Ratings RMSYFRamsay Health Care Ltd.0 0 0 KZIAKazia Therapeutics Ltd.0 0 0 -
Is RMSYF or KZIA More Risky?
Ramsay Health Care Ltd. has a beta of 0.096, which suggesting that the stock is 90.419% less volatile than S&P 500. In comparison Kazia Therapeutics Ltd. has a beta of 1.672, suggesting its more volatile than the S&P 500 by 67.185%.
-
Which is a Better Dividend Stock RMSYF or KZIA?
Ramsay Health Care Ltd. has a quarterly dividend of $0.25 per share corresponding to a yield of 0%. Kazia Therapeutics Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ramsay Health Care Ltd. pays 2698.46% of its earnings as a dividend. Kazia Therapeutics Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RMSYF or KZIA?
Ramsay Health Care Ltd. quarterly revenues are --, which are smaller than Kazia Therapeutics Ltd. quarterly revenues of --. Ramsay Health Care Ltd.'s net income of -- is lower than Kazia Therapeutics Ltd.'s net income of --. Notably, Ramsay Health Care Ltd.'s price-to-earnings ratio is 4,444.44x while Kazia Therapeutics Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ramsay Health Care Ltd. is 0.40x versus 680.02x for Kazia Therapeutics Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RMSYFRamsay Health Care Ltd.0.40x 4,444.44x -- -- KZIAKazia Therapeutics Ltd.680.02x -- -- --
-
Which has Higher Returns RMSYF or MESO?
Mesoblast Ltd. has a net margin of -- compared to Ramsay Health Care Ltd.'s net margin of --. Ramsay Health Care Ltd.'s return on equity of 0.49% beat Mesoblast Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RMSYFRamsay Health Care Ltd.-- -- $10.4B MESOMesoblast Ltd.-- -- -- -
What do Analysts Say About RMSYF or MESO?
Ramsay Health Care Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Mesoblast Ltd. has an analysts' consensus of $35.00 which suggests that it could grow by 95.86%. Given that Mesoblast Ltd. has higher upside potential than Ramsay Health Care Ltd., analysts believe Mesoblast Ltd. is more attractive than Ramsay Health Care Ltd..
Company Buy Ratings Hold Ratings Sell Ratings RMSYFRamsay Health Care Ltd.0 0 0 MESOMesoblast Ltd.1 0 0 -
Is RMSYF or MESO More Risky?
Ramsay Health Care Ltd. has a beta of 0.096, which suggesting that the stock is 90.419% less volatile than S&P 500. In comparison Mesoblast Ltd. has a beta of 2.025, suggesting its more volatile than the S&P 500 by 102.508%.
-
Which is a Better Dividend Stock RMSYF or MESO?
Ramsay Health Care Ltd. has a quarterly dividend of $0.25 per share corresponding to a yield of 0%. Mesoblast Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ramsay Health Care Ltd. pays 2698.46% of its earnings as a dividend. Mesoblast Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RMSYF or MESO?
Ramsay Health Care Ltd. quarterly revenues are --, which are smaller than Mesoblast Ltd. quarterly revenues of --. Ramsay Health Care Ltd.'s net income of -- is lower than Mesoblast Ltd.'s net income of --. Notably, Ramsay Health Care Ltd.'s price-to-earnings ratio is 4,444.44x while Mesoblast Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ramsay Health Care Ltd. is 0.40x versus 125.41x for Mesoblast Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RMSYFRamsay Health Care Ltd.0.40x 4,444.44x -- -- MESOMesoblast Ltd.125.41x -- -- --
-
Which has Higher Returns RMSYF or PPCB?
has a net margin of -- compared to Ramsay Health Care Ltd.'s net margin of --. Ramsay Health Care Ltd.'s return on equity of 0.49% beat 's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RMSYFRamsay Health Care Ltd.-- -- $10.4B PPCB-- -$0.00 -- -
What do Analysts Say About RMSYF or PPCB?
Ramsay Health Care Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand has an analysts' consensus of -- which suggests that it could fall by --. Given that Ramsay Health Care Ltd. has higher upside potential than , analysts believe Ramsay Health Care Ltd. is more attractive than .
Company Buy Ratings Hold Ratings Sell Ratings RMSYFRamsay Health Care Ltd.0 0 0 PPCB0 0 0 -
Is RMSYF or PPCB More Risky?
Ramsay Health Care Ltd. has a beta of 0.096, which suggesting that the stock is 90.419% less volatile than S&P 500. In comparison has a beta of 1.881, suggesting its more volatile than the S&P 500 by 88.104%.
-
Which is a Better Dividend Stock RMSYF or PPCB?
Ramsay Health Care Ltd. has a quarterly dividend of $0.25 per share corresponding to a yield of 0%. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ramsay Health Care Ltd. pays 2698.46% of its earnings as a dividend. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RMSYF or PPCB?
Ramsay Health Care Ltd. quarterly revenues are --, which are smaller than quarterly revenues of --. Ramsay Health Care Ltd.'s net income of -- is lower than 's net income of -$354.3K. Notably, Ramsay Health Care Ltd.'s price-to-earnings ratio is 4,444.44x while 's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ramsay Health Care Ltd. is 0.40x versus -- for . Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RMSYFRamsay Health Care Ltd.0.40x 4,444.44x -- -- PPCB-- -- -- -$354.3K
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 48.08% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 5.53% over the past day.
Sell
13
PSN alert for Dec 8
Parsons Corp. [PSN] is down 5.72% over the past day.
